Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre-Reference-Cited by-同舟云学术

Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre

Published:2021-01-12 Issue:7 Volume:23 Page:1452-1462
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Valero J.,Montero A.^ORCID,Hernando O.,Izquierdo M.,Sánchez E.,García-Aranda M.,López M.,Ciérvide R.,Martí J.,Álvarez B.,Alonso R.,Chen-Zhao X.,Fernández-Letón P.,Rubio C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-020-02543-z.pdf

Reference46 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, in press. The online GLOBOCAN 2018 database is accessible at http://gco.iarc.fr/, as part of IARC’s Global Cancer Observatory

2. Swanson GP, Riggs M, Hermans M. Pathologic findings at radical prostatectomy: risk factors for failure and death. UrolOncol. 2007;25:110–4. https://doi.org/10.1016/j.urolonc.2006.06.003.

3. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15 year Johns Hopkins experience. Urol Clin North Am. 2001;28:555–65. https://doi.org/10.1016/S0094-0143(05)70163-4.

4. Stephenson AJ, Bolla M, Briganti A, et al. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol. 2012;61(3):443–512.

5. Wiegel T, Bottke D, Bartkowiak D, et al. The 10-years follow-up of the ARO 96–02/AUO AP 09/95 trial on adjuvant radiotherapy (ART) versus wait-and-see (WS) after prostatectomy for pT3 cancer-subgroup analysis. Eur Urol Suppl. 2013;12(1):e192–3.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome;Life;2023-07-23

2. The Latest Data Specifically Focused on Long-Term Oncologic Prognostication for Very Old Adults with Acute Vulnerable Localized Prostate Cancer: A Nationwide Cohort Study;Journal of Clinical Medicine;2022-06-15

3. Moderately hypofractionated salvage radiotherapy in patients with biochemical recurrence of prostate cancer after prostatectomy: long-term results and comparative analysis of two schedules;Neoplasma;2022